the diagnosis and management of fungal pneumonia

Depending on the immunologic status of fungal pneumonia patients, different treatment strategies are adopted, including empiric antifungal therapy and preemptive therapy, and adverse drug reactions and efficacy should be closely monitored during treatment.

Invasive pulmonary mycosis should be considered in patients with clear risk factors for fungal infection

. Patients with clinically suspected invasive pulmonary mycosis should be treated

preemptively. Patients with low

immune function should be individually treated.

Antifungal therapy should be given to patients with confirmed or highly suspected invasive pulmonary mycosis

. For patients who cannot be diagnosed definitively, empiric antifungal therapy can be given.

Adverse reactions and efficacy of drugs should be closely monitored during treatment.

Key message: Depending on the immune function status of patients with fungal pneumonia, different treatment strategies should be adopted, including empiric antifungal therapy and preemptive treatment, while adverse reactions and efficacy of drugs should be closely monitored.